T38.89 Poisoning by, adverse effect of and underdosing of other hormones and synthetic substitutes

Name of the Condition

• Poisoning by, adverse effect of and underdosing of other hormones and synthetic substitutes

Summary

This condition encompasses adverse effects, poisoning, or underdosing related to hormones and their synthetic substitutes when the specific agent is not classified elsewhere. It includes reactions to these substances that are not assigned to more specific codes, covering scenarios where the exact hormone or substitute is unspecified or the event is not assigned to a more specific code.

Causes

The causes involve exposure to hormones, their synthetic analogues, or antagonists, which may result from therapeutic use, accidental ingestion, or incorrect dosing. Adverse effects can arise from the pharmacological properties of these agents, while underdosing may stem from insufficient administration or non-adherence.

Risk Factors

• Use of hormone therapies or antagonists for medical conditions
• Polypharmacy involving hormonal agents
• Incorrect dosing or administration
• Individual sensitivity to hormonal substances
• Renal or hepatic impairment affecting drug metabolism

Symptoms

Symptoms vary based on the specific hormone or agent involved and may include metabolic disturbances, endocrine imbalances, or organ-specific effects. Adverse reactions could manifest as hyper- or hypofunction of target systems, while underdosing may lead to inadequate therapeutic response.

Diagnosis

Diagnosis requires a thorough patient history, including medication use, clinical presentation, and laboratory findings to identify the specific hormone or agent involved. Clinical assessment and toxicology screening may be necessary to confirm exposure or adverse effects.

Treatment Options

Treatment depends on the specific hormone or agent, the severity of the reaction, and whether it is an overdose or underdose. Management may include discontinuation of the offending agent, supportive care, antidotes (if available), or dose adjustments to restore therapeutic levels.

Prognosis and Follow-Up

Prognosis varies based on the specific hormone, the extent of exposure, and timely intervention. Follow-up may involve monitoring endocrine function, adjusting medications, and addressing any underlying conditions contributing to the adverse effect or underdosing.

Complications

Complications can include persistent endocrine dysfunction, organ damage from toxicity, or inadequate treatment response due to underdosing. Severe cases may require long-term management or specialist care.

Lifestyle & Prevention

Prevention involves proper medication management, adherence to prescribed dosing, and avoiding self-medication with hormonal agents. Patients should be educated on the risks of polypharmacy and the importance of reporting adverse effects promptly.

When to Seek Professional Help

Seek medical attention if symptoms of hormonal imbalance, toxicity, or inadequate treatment response occur, especially after starting or changing hormone therapy. Immediate care is needed for severe reactions, such as altered consciousness, severe metabolic disturbances, or organ failure.

Tips for Medical Coders

When coding T38.89, ensure documentation supports the use of "other hormones and synthetic substitutes" not classified to more specific codes. Verify the agent is not assigned to a narrower category (e.g., anterior pituitary hormones) and that the event (poisoning, adverse effect, or underdosing) is clearly documented. Include details on the specific hormone or substitute when available to support code assignment.